Join
Live feed
·
INSIDERFilingvia Quantisnow
Akari Therapeutics plc logo

Director Patel Samir Rashmikant was granted 1,404,622,000 units of Ordinary Shares (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
AKTX· Akari Therapeutics plc
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track AKTX (Akari Therapeutics plc) and more on Quantisnow.